chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started getting brain fog right away and then on the same day of the vaccine I mild body aches and wrist pain on left. And that was mild for three days except for wrist pain and that progressively got worse. I ended up going to the ER  twice because of it. It was excruciating pain, it felt like every bone in my hand was crushed (and I'm a lefty). I couldn't do anything with my hand. I can't remember the dates I went to ER for it. At my first visit, they gave me a shot (a muscle relaxer) and some pills. The second time, they gave me a CT scan. They said my vaccine caused me to have an extreme flare-up of the fibromyalgia and it lasted about 5 or 6 weeks that I had the pain. The second time I went they also gave me shots and pain meds, I think they gave me muscle relaxers. They may have sent me home with medication. My wrist was weak, also. I still have real mild pain but not anything near where it was. It might feel a twinge weak still but just a little. I got a virus from my asthma, July 26th, a week before this I started having headaches for about four or five days, they were mild but then I started having trouble breathing for two days and then I got extremely weak and tired. I was treating it as asthma with my  normal medications. My emotional support dog was literally freaking out and she did not want to leave me and was crying. So I went to the hospital and that is when I went to July 26th. I had no intention of going to the hospital but the way my dog was acting had me concerned had me go in and she saved my life. They admitted me, at first they treated me for my asthma but then they tested me for COVID and the doctor examined me again and they kept me because he tested and it was positive. I had been isolating so it never occurred to me that I had COVID. I had not been anywhere. The first thing they gave me was vitamins, vit D3 and zinc and I think magnesium (this is 15 minutes after positive COVID test). I think after admission I was getting antibiotics and steroids. I was giving the med they gave others, remdesidir, or whatever it's called. At first what they gave me didn't help me but once they gave me the remdesidir, then things started to feeling better. Currently it is going in stages, I have trouble breathing on one day, the next day, I am fine and then I'm not feeling well again. They sent me home with Eliquis, and an inhaler and another med. I am done with all of them. I need a follow up with the doctor. Trying to do my asthma meds because I haven't been able to get to doctor, have had no access to doctor and so I have been on my own with treatment which is scary with asthma and COVID. October 4 is when I can see the doctor. Still having cough and sometimes I have the mild headaches and I still have the fatigue, I always have the fatigue. I haven't been able to walk my dog for the month. I can't find anyone else to help care for her now that I'm home. Shortness of breath comes and goes.
Sleeping all day after DTP, OPV #1.  Mother states she changed pt's diaper & she didn't wake up or open her eyes. Awake next day & fussy.
The left arm has a softball sized rash that is itchy and has raised bumps. There is a ring on the outer part of the inflamed area.
This is an initial spontaneous report by a contactable physician. A Pfizer sales representative reported on behalf of a physician for a currently 13-month-old female patient who received a fourth dose (0.5 ml) of PREVNAR 13, intramuscularly on an unspecified day in Feb2012 as immunization for prevention of streptococcus pneumoniae and a dose of VARICELLA VACCINE administered on the same (unspecified) day in Feb2011. Past product history was unknown. The patient had no relevant medical history or concomitant medications. In Feb2012, post-vaccination, the patient experienced a 108 degree Celsius fever and febrile seizure for which she was hospitalized. Therapeutic measures taken in response to febrile seizure included ATIVAN. On an unspecified date in 2012 the patient also aspirated for which she was transferred to a hospital. It was unknown if the patient had any siblings. Relevant laboratory data was unknown. At the time of the report she had not recovered from the above mentioned events.
About 5 or 6 hours after injection of Moderna dose #2, I experienced the onset of fever and a massive headache that prevented me from sleeping more than 2 to 10 minutes at a time - all night.  The next day, the intense headache persisted until late afternoon. Fever broke around the same time but my forehead was still warm 48 hours later. I was fully functional, however,  within 48 hours of injection.   (Side note: After Moderna dose #1,  I previously reported on VAERS an itchy red welt at the injection site that emerged exactly one week after the shot. I opted to get dose #2 in the same arm, however, so both shots were in the Left arm.)
Itching Rash which lasted all summer--moving from one part of body to another.  Treated by a dermatologist--all summer--used topical steroid, benadryl, and po visteril--did allergy testing--attempted to stay away from food that was on list--unsuccessful and started on Dupixent, which has helped.
Patient stated arm had been sore for a month and consulted Dr. who said it was given in bursa sac by patients description of vaccination.
Patient had received his booster Moderna shot.  After about ten minutes, he tried to get up from his chair.  He slumped and fainted, and he seized for about five seconds before coming to.  He did cut his nose (we're not entirely sure how).  I had him lie on the floor with his feet elevated because he stated he felt lightheaded.  Paramedics were called, and they took over.
The day of vaccine I had a sore arm. I could barely move arm, slight fever, nauseated, and I felt like I had flu symptoms and I think they only lasted a day and I did not need medical care. My arm soreness last a week. I had a really bad cough in August that no one seemed to be able to treat. I insisted to see a Pulmonary doctor who did a biopsy. When I woke up I was diagnosed with Lung Cancer in September.  I am cancer free now.
Body aches and fatigue for 24 hours, started about 4 hours after receiving shot. Muscle soreness in arm is persistent.
This is a spontaneous report received from a contactable consumer or other non HCP. A 44-year-old female patient (not pregnant) received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 44, on Mar 23, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The following information patient developed a vaccination site mass (bump next to Band-Aid), onset Mar 23, 2021, with outcome of unknown. Therapeutic measures were not taken as a result of vaccination site mass. Additional information: The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. Patient stated it may have been on the vaccine shot site but it was not under the Band-Aid. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
can't raise that arm; extreme pain at the injection site weeks after the second vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (can't raise that arm) and VACCINATION SITE PAIN (extreme pain at the injection site weeks after the second vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (can't raise that arm) and VACCINATION SITE PAIN (extreme pain at the injection site weeks after the second vaccine). At the time of the report, MOBILITY DECREASED (can't raise that arm) and VACCINATION SITE PAIN (extreme pain at the injection site weeks after the second vaccine) outcome was unknown.            No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Fevers of 103, cough x 2-3 days. Took TYLENOL and cough med. Sibling had similar symptoms.
This spontaneous report was received from a registered nurse referring to a 10 year-old patient of unknown gender. The patient's pertinent medical history and concurrent conditions were not provided.    On 13-DEC-2017 , the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot # N004799, expiration date on 15-NOV-2019 or lot #N021475, expiration date on 21-JAN-2020, for prophylaxis (strength and route were not reported). The vaccine was stored at a temperature of 50°F for a time frame of 2 hours. No adverse effects neither previous temperature excursions for the improperly stored vaccine were reported. The call was because of a data logger. This case was one of several reports received from the same reporter. ; Sender's Comments: US-009507513-1801USA002510: US-009507513-1801USA002511: US-009507513-1801USA002512: US-009507513-1801USA002513: US-009507513-1801USA002515: US-009507513-1801USA002516: US-009507513-1712USA010085: US-009507513-1801USA002518: US-009507513-1801USA002519: US-009507513-1801USA002520: US-009507513-1801USA002521: US-009507513-1801USA002522: US-009507513-1801USA002509: US-009507513-1801USA002508: US-009507513-1801USA002514:
Patient experienced rash down inside of both arms, rash up the neck, rash up under the chin, and on both face cheeks. She complains of intense itching and took it upon herself to start Benadryl (OTC antihistamine).
HIVES ON SCALP ONSET IS APPROX BUT I HAVE HAD THEM FOR ABOUT 3 WEEKS, COULD BE COINCIDENTAL TO INJECTION
No reactions occurred. Vaccine administered on 5/12/2022, however due to it being kept in the fridge, it should have expired on 4/8/22, therefore patient received expired vaccine.
Smell/taste; Smell/taste; Foggy brain; Long-haul symptoms that re-surfaced; Headaches; Exhaustion reemerged soon after my second shot; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Smell/taste), AGEUSIA (Smell/taste), FEELING ABNORMAL (Foggy brain), SYMPTOM RECURRENCE (Long-haul symptoms that re-surfaced) and HEADACHE (Headaches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had Covid in December or January).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANOSMIA (Smell/taste), AGEUSIA (Smell/taste), FEELING ABNORMAL (Foggy brain), SYMPTOM RECURRENCE (Long-haul symptoms that re-surfaced), HEADACHE (Headaches) and FATIGUE (Exhaustion reemerged soon after my second shot). At the time of the report, ANOSMIA (Smell/taste), AGEUSIA (Smell/taste), FEELING ABNORMAL (Foggy brain), SYMPTOM RECURRENCE (Long-haul symptoms that re-surfaced), HEADACHE (Headaches) and FATIGUE (Exhaustion reemerged soon after my second shot) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.
This spontaneous report was received from a registered nurse via a company representative refers to a 70-year-old female patient. On 04-NOV-2011 the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # 0813AA, expiration date 17-MAR-2013) dose and route not reported. No concomitant medications were reported. On 05-NOV-2011 the patient developed a fever of 101 Fahrenheit (F). On 08-NOV-2011 the patient developed hives on an unspecified area of the body. The patient went to an unspecified walk-in clinic. The patient was given prednisone (dose and manufacturer unspecified). The patient recovered on an unspecified date. The patient sought medical attention for the events. No further information is available. Additional information has been requested.
Around 4pm I started to feel sick and i started to feel really cold, chills. I got a migraine so I laid down. Around 7pm I started feeling nauseous and started throwing up around 730p. Around midnight I started getting really hot. I checked my temp it was 101. 230a I woke up and checked temp it was 102.9. Symptoms lasted until around noon next day.
This spontaneous report as received from a 50 year old female nurse regarding herself. The patient had no drug reactions or allergies and pertinent medical history. On 05-NOV-2013 the patient was vaccinated with ZOSTAVAX (dose unknown) in the right arm for vaccination. There were no concomitant medications. On 06-NOV-2013, the patient experienced rash that was a red, raised patch 2.5 centimeters in circumference at the injection site of the right arm. The outcome of the events was reported as not recovered/not resolved. Additional information is not expected.
On 4/12/00, the pt developed facial swelling on the right followed by a rash which spread over the face, neck, chest, back, and some areas of the arms and legs. The reporter noted that the pt had a fever of 104-105 but he did not have lesions in his mouth. The reporter indicated that the pt received therapy with cephalexin for treatment of the swollen cheek after the vax. At the time of the report, 5/18/00, the reporter indicated that the pt was intubated and hospitalized in an ICU. The reporter indicated that the events were life threatening.  Follow-up information dated 9/26/00 stated that a bone marrow biopsy showed Natural Killer Cell Lymphoma. The pt died in the hospital on 5/25/00 after a 10 day admission. It was noted that the final cause of death was Natural Killer Cell Lymphoma.
Patient presented to ED on 2/14/22 (2 days after booster vaccine on 2/12/22) reported chest pain, fever. Troponin was elevated and echo showed reduced ejection fraction and hypokinesis.  Patient was diagnosed with myocarditis and received treatment of aspirin, colchicine, and prednisone.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021 at 10:40 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2021 at 10:40 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No concomitant medication was reported by reporter. Batch number 031L20A underwent temperature excursion on 14-Feb-2021 with temperature 32 degrees Fahrenheit at 09:00 AM, 10:00 AM and 11:00 AM. Temperature 32 degrees Fahrenheit at 14:00 PM and 13:00 PM. This vial was moved to fridge on 09-Feb-2021 and beyond use date for the vial was reported as 10-Mar-2021. Product moved to clinic on 13-Jan-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. Temperature recordings were taken by using a  traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided.
Twelve hours after receiving the second Covid injection, I had severe chills, night sweats, mild fever, general weakness,  and malaise. The symptoms gradually subsided the next 12-24 hours.
This spontaneous report was received from a healthcare professional refers to an unspecified patients of unknown age and gender. No pertinent medical history was reported. On unknown dates in 2015 (reported as "since 17-JUL-2015"), the patients were vaccinated with doses of PROQUAD (Merck) (dose and route were not reported) lot # L002419, expiration date 23-JUL-2016 and lot # L007230 expiration date 03-SEP-2016 which were improperly stored. No adverse experience reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
Redness, itching, and pain - big patch of red appearing surrounding injection site 1 week later
I feel weak until now; Low temp fever; Chill; Super tired; Sore of my arms; After 1week i start palpiting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore of my arms), PALPITATIONS (After 1week i start palpiting), ASTHENIA (I feel weak until now), PYREXIA (Low temp fever) and CHILLS (Chill) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced PALPITATIONS (After 1week i start palpiting). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore of my arms), ASTHENIA (I feel weak until now), PYREXIA (Low temp fever), CHILLS (Chill) and FATIGUE (Super tired). At the time of the report, PAIN IN EXTREMITY (Sore of my arms), PALPITATIONS (After 1week i start palpiting), PYREXIA (Low temp fever), CHILLS (Chill) and FATIGUE (Super tired) outcome was unknown and ASTHENIA (I feel weak until now) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low temperature fever (High) low temperature fever.         Concomitant product use was not provided by the reporter.   No treatment information was provided.
Following MMR injection on 5-31, pt developed viral prodrome with URI sx on 6-08, then a Measles rash (whole body) 2 days later with persistent myalgias, arthralgias, off/on rash, malaise that is present to date 8-02.
Pt recvd vax & exp SOB, h/a, nausea & difficulty swallowing;
Patient  is a 34-year-old, female. Alert, oriented X3, clear speech, able to answer to the questions. Underlying medical conditions include ankylosing spondylitis. No history of allergies. Denied having allergies to food, other vaccines, or components of COVID-19 vaccine. At 9:46 am, the patient received her first dose of Janssen (lot number 1808980, expires on 06/20/2021) on left deltoid, given by RN . Patient continued to be A&Ox3, walked herself over to the EMT waiting area with a steady, balanced, and sat down. At 10:10 am, while waiting in observation area, patient reported feeling "light-headed".  EMT responded by offering the client a water bottle, assisting her to anti-gravity chair, and taking the patient's vitals (BP 116/78, HR 83). Patient stated she did not have anything to eat or drink before vaccination. Vial signs were taken every 5 minutes. At 10:15 am, BP 118/82, Sp02 at 98% room air, HR 82bpm. At 10:20 am, BP 118/78 sitting, HR 91 bpm, respirations unlabored. At 10:25 am, BP 118/82, HR 81, RR 20 res/min, unlabored, SpO2 97%. At 10:30 am, BP 116/78, SpO2 97%, HR 80 bpm, RR 20 res/min, unlabored, patient ingested 250 ml of water, denied any discomfort. Patient denies lightheadedness. Patient education was provided to patient about signs and symptoms of allergic reaction (tightness in chest) and was told to follow up with PCP. She verbalized understanding. At 10:35 am, BP 116/82, HR 80 , RR 20 res/min, unlabored, SpO2 97%. At 10:40 am, BP 116/74, HR 78 , RR 20 res/min, unlabored, SpO2 98%. Patient left facility at 1047, accompanied by husband to their car. Patient was able to walk without assistance, gait was balanced. Patient's husband stated he would be driving her home.
Per internal reported event: COVID Vaccine 12/30/20 @ 0940. reported feeling hot and unsteady 0948. assisted pt to wheelchair, given water. Monitored and offered to take to ED, pt declined. Reports sx resolved and ambulated home with steady gait at 1003.
pain and a swelling under the arm; pain and a swelling under the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain and a swelling under the arm) and PERIPHERAL SWELLING (pain and a swelling under the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain and a swelling under the arm) and PERIPHERAL SWELLING (pain and a swelling under the arm). At the time of the report, PAIN IN EXTREMITY (pain and a swelling under the arm) and PERIPHERAL SWELLING (pain and a swelling under the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Pt to ED 8/20 for acute mental change. 9/15 pt had temp 101, with a cough. 9/16 pt COVID+, rx remdesivir for 3 days. 9/17 pt A&OX2, no sign of distress or pain. 9/18 pt a&ox2, no needs expressed. No sign of discomfort or distress. Pt discharged 9/19.